Eovist Contrast Media Gadoxetate Disodium 181.43 mg / mL Intravenous Injection Single Dose Vial 15 mL , 5/Box MC 50419032015

Eovist Contrast Media Gadoxetate Disodium 181.43 mg / mL Intravenous Injection Single Dose Vial 15 mL , 5/Box MC 50419032015

1- REGULATIONS ON PURCHASE OF THESE PRODUCTS VARY FROM STATE TO STATE . IT IS THE PURCHASER'S RESPONSIBILITY TO KNOW AND COMPLY WITH THE LAWS GOVERNING THE DISTRICT IN WHICH THEY LIVE.
2-THESE ITEMS WOULD BE USED ONLY BY QUALIFIED CUSTOMERS ( PHYSICIAN OFFICES , DIAGNOSTIC & RESEARCH LABORATORIES , HEALTH CARE PROVIDERS , .... ) WITH VALID PROFESSIONAL LICENSE.
3- ANY INQUIRY REGARDING THESE ITEMS WOULD BE PROCESSED AFTER VERIFICATION OF VALID LICENSE TO BE EMAILED AS AN ATTACHMENT TO : ADMIN@ALLMEDTECH.COM OR FAXED TO 323-782-0985 )

Manufacturer # 50419032015 Brand Eovist® Manufacturer McKesson Specialty Application Contrast Media Container Type Single Dose Vial Dosage Form Injection Generic Drug Code 13287 Generic Drug Name Gadoxetate Disodium NDC Number 50419-0320-15 Strength 181.43 mg / mL Type Intravenous UNSPSC Code 51442200 Volume 15 mL

Features

• Eovist® is a gadolinium-based MRI-contrast agent approved for intravenous use in magnetic resonance imaging (MRI) of the liver to detect and characterize lesions in patients with known or suspected focal liver disease
• Eovist® injection is supplied in single-dose, rubber-stoppered vials containing 181.43 mg/mL of gadoxetate disodium, equivalent to 0.25 mmol/mL